Product Information

DEXTROAMP-AMPHET ER 10 MG CAP is a generic product labeled by Rhodes Pharmaceuticals L.P., priced at $0.5272 per EA under NDC 42858061001. Its NADAC has been published 358 times since Oct 16, 2019.

FDA first approved this application on May 17, 2019. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The Low Outlier badge above means this manufacturer's average price in the DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE, and AMPHETAMINE SULFATE market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

Low Outlier
DEA Schedule CII

Strength

2.5; 2.5; 2.5; 2.5 mg/1; mg/1; mg/1; mg/1

NDC

42858061001

Classification

Generic

Dosage Form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Effective Date

8/19/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA210651

FDA Approved

5/17/2019

TE Code

AB1

On Market Since

8/22/2019

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulation
Central Nervous System Stimulation
Central Nervous System Stimulation
Central Nervous System Stimulation

Price Statistics

The NADAC for DEXTROAMP-AMPHET ER 10 MG CAP has been published 358 times since Oct 16, 2019, and over the history we have for it it has declined 70.3%. The table below summarizes its recorded NADAC range and movement.

Current price$0.5272 per EA
All-time high$1.7743 (Oct 16, 2019)
All-time low$0.3703 (Jul 17, 2024)
52-week high$0.6088
52-week low$0.4861
Median price$0.5959
Average price$0.7207
Largest weekly change+63.7% (Aug 21, 2024)
Weeks tracked358
Tracking sinceOct 16, 2019

Price History

1W

+1.5%

1M

+1.5%

3M

+2.5%

6M

+3.6%

1Y

-13.4%

3Y

-8.7%

5Y

-23.5%

All

-70.3%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of DEXTROAMP-AMPHET ER 10 MG CAP?

The current National Average Drug Acquisition Cost (NADAC) for DEXTROAMP-AMPHET ER 10 MG CAP, manufactured by Rhodes Pharmaceuticals L.P., is $0.5272 per EA (NDC 42858061001), effective Aug 19, 2026.

How has the price of DEXTROAMP-AMPHET ER 10 MG CAP changed over time?

Over the history we have for it, the NADAC for DEXTROAMP-AMPHET ER 10 MG CAP has declined 70.3%. It has been tracked across 358 weekly CMS publications since Oct 16, 2019.

What are the highest and lowest recorded NADAC prices for DEXTROAMP-AMPHET ER 10 MG CAP?

Since Oct 16, 2019, the NADAC for DEXTROAMP-AMPHET ER 10 MG CAP has ranged from a low of $0.3703 (Jul 17, 2024) to a high of $1.7743 (Oct 16, 2019), with a median of $0.5959 per EA.

Are there cheaper alternatives to DEXTROAMP-AMPHET ER 10 MG CAP?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DEXTROAMP-AMPHET ER 10 MG CAP in a comparable dosage form, but none are currently priced below it.

Who manufactures DEXTROAMP-AMPHET ER 10 MG CAP?

DEXTROAMP-AMPHET ER 10 MG CAP (NDC 42858061001) is labeled by Rhodes Pharmaceuticals L.P., and CMS classifies it as a generic product.